Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Neurosci ; 33(14): 6047-59, 2013 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-23554486

RESUMEN

Dysregulated hippocampal neurogenesis has been associated with neurodegenerative disorders, including Alzheimer's disease (AD), in which it may potentially represent an auto-reparatory mechanism that could counteract neuronal loss and cognitive impairment. We evaluated hippocampal neurogenesis in TgCRND8 mice and reported that, at 32 weeks of age, corresponding to an advanced AD-like neuropathology stage, increased numbers of proliferating cells, doublecortin-expressing progenitors/neuroblasts, and early postmitotic calretinin-expressing neurons were present compared with wild-type (WT) littermates. When hippocampal neural progenitor cells (NPCs) were isolated from TgCRND8 mice, we demonstrated that (1) their neurogenic potential was higher compared with WT NPCs; (2) medium conditioned by TgCRND8 NPC promoted neuronal differentiation of WT NPCs; and (3) the proneurogenic effect of TgCRND8-conditioned medium was counteracted by blockade of the receptor for advanced glycation end products (RAGE)/nuclear factor-κB (NF-κB) axis. Furthermore, we showed that ß-amyloid 1-42 (Aß(1-42)) oligomers, but not monomers and fibrils, and the alarmin high-mobility group box-1 protein (HMGB-1) could promote neuronal differentiation of NPCs via activation of the RAGE/NF-κB axis. Altogether, these data suggest that, in AD brain, an endogenous proneurogenic response could be potentially triggered and involve signals (Aß(1-42) oligomers and HMGB-1) and pathways (RAGE/NF-κB activation) that also contribute to neuroinflammation/neurotoxicity. A more detailed analysis confirmed no significant increase of new mature neurons in hippocampi of TgCRND8 compared with WT mice, suggesting reduced survival and/or integration of newborn neurons. Therapeutic strategies in AD should ideally combine the ability of sustaining hippocampal neurogenesis as well as of counteracting an hostile brain microenvironment so to promote survival of vulnerable cell populations, including adult generated neurons.


Asunto(s)
Péptidos beta-Amiloides/farmacología , Diferenciación Celular/efectos de los fármacos , Productos Finales de Glicación Avanzada/metabolismo , Proteína HMGB1/farmacología , Hipocampo/citología , Subunidad p50 de NF-kappa B/metabolismo , Fragmentos de Péptidos/farmacología , Células Madre Adultas/efectos de los fármacos , Células Madre Adultas/fisiología , Factores de Edad , Precursor de Proteína beta-Amiloide/genética , Análisis de Varianza , Animales , Animales Recién Nacidos , Bromodesoxiuridina , Muerte Celular/efectos de los fármacos , Muerte Celular/genética , Inhibidores Enzimáticos/farmacología , Ensayo de Inmunoadsorción Enzimática , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Humanos , L-Lactato Deshidrogenasa/metabolismo , Masculino , Ratones , Ratones Transgénicos , Mutación/genética , Subunidad p50 de NF-kappa B/deficiencia , Proteínas del Tejido Nervioso/metabolismo , Neuronas/efectos de los fármacos , Neuronas/fisiología , Factores de Transcripción SOXB1/metabolismo , Transducción de Señal/efectos de los fármacos
2.
Mol Pharmacol ; 82(2): 271-80, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22572885

RESUMEN

Although the role of adult hippocampal neurogenesis remains to be fully elucidated, several studies suggested that the process is involved in cognitive and emotional functions and is deregulated in various neuropsychiatric disorders, including major depression. Several psychoactive drugs, including antidepressants, can modulate adult neurogenesis. Here we show for the first time that the α2δ ligands gabapentin [1-(aminomethyl)cyclohexaneacetic acid] and pregabalin (PGB) [(S)-(+)-3-isobutyl-GABA or (S)-3-(aminomethyl)-5-methylhexanoic acid] can produce concentration-dependent increases in the numbers of newborn mature and immature neurons generated in vitro from adult hippocampal neural progenitor cells and, in parallel, a decrease in the number of undifferentiated precursor cells. These effects were confirmed in vivo, because significantly increased numbers of adult cell-generated neurons were observed in the hippocampal region of mice receiving prolonged treatment with PGB (10 mg/kg i.p. for 21 days), compared with vehicle-treated mice. We demonstrated that PGB administration prevented the appearance of depression-like behaviors induced by chronic restraint stress and, in parallel, promoted hippocampal neurogenesis in adult stressed mice. Finally, we provided data suggesting involvement of the α2δ1 subunit and the nuclear factor-κB signaling pathway in drug-mediated proneurogenic effects. The new pharmacological activities of α2δ ligands may help explain their therapeutic activity as supplemental therapy for major depression and depressive symptoms in post-traumatic stress disorder and generalized anxiety disorders. These data contribute to the identification of novel molecular pathways that may represent potential targets for pharmacological modulation in depression.


Asunto(s)
Aminas/metabolismo , Canales de Calcio/metabolismo , Diferenciación Celular/efectos de los fármacos , Ácidos Ciclohexanocarboxílicos/metabolismo , Depresión/prevención & control , Hipocampo/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Estrés Psicológico/tratamiento farmacológico , Ácido gamma-Aminobutírico/análogos & derivados , Aminas/farmacología , Aminas/uso terapéutico , Animales , Diferenciación Celular/fisiología , Ácidos Ciclohexanocarboxílicos/farmacología , Ácidos Ciclohexanocarboxílicos/uso terapéutico , Depresión/etiología , Depresión/metabolismo , Gabapentina , Hipocampo/citología , Hipocampo/metabolismo , Ligandos , Masculino , Ratones , Ratones Endogámicos C57BL , Neurogénesis/fisiología , Pregabalina , Distribución Aleatoria , Restricción Física , Estrés Psicológico/complicaciones , Estrés Psicológico/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Ácido gamma-Aminobutírico/farmacología , Ácido gamma-Aminobutírico/uso terapéutico
3.
Mol Cell Neurosci ; 45(2): 139-50, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20600932

RESUMEN

The Receptor for Advanced Glycation End-products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptors which interacts with a wide range of ligands, such as High-Mobility Group Box-1 (HMGB-1), S100B, advanced glycation end-products (AGEs). Here we provided evidence for the restricted expression of RAGE in the undifferentiated neural stem/progenitor cells of mouse adult SubVentricular Zone (SVZ) neurogenic region and adult SVZ-derived neurospheres. Additionally, RAGE ligands stimulated both proliferation and neuronal differentiation of SVZ-derived neural progenitor cells (NPC) in vitro. NF-kappaB nuclear translocation occurred upon RAGE activation in SVZ-derived neurospheres and its blockade (by SN-50) or its absence (in p50(-/-) derived NPC) resulted in the inhibition of the ligand-mediated effects on neuronal differentiation. These novel findings delineate an interesting scenario where the RAGE-NF-kappaB axis may contribute to regulate adult neural stem/progenitor cell function in physiological and possibly pathological conditions where this axis is upregulated.


Asunto(s)
Ventrículos Cerebrales/citología , Productos Finales de Glicación Avanzada/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Células-Madre Neurales/fisiología , Receptores Inmunológicos/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Productos Finales de Glicación Avanzada/farmacología , Masculino , Ratones , FN-kappa B/metabolismo , Células-Madre Neurales/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Receptor para Productos Finales de Glicación Avanzada , Regulación hacia Arriba
4.
J Neurosci ; 28(15): 3911-9, 2008 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-18400889

RESUMEN

Neurogenesis proceeds throughout adulthood in the brain of most mammalian species, but the molecular mechanisms underlying the regulation of stem/progenitor cell proliferation, survival, maturation, and differentiation have not been completely unraveled. We have studied hippocampal neurogenesis in NF-kappaB p50-deficient mice. Here we demonstrate that in absence of p50, the net rate of neural precursor proliferation does not change, but some of the steps leading to the final neuron differentiation status are hampered, resulting in approximately 50% reduction in the number of newly born neurons in the adult mutant hippocampus. Additionally, in p50(-/-) mice, we observed a selective defect in short-term spatial memory performance without impairment of hippocampal-dependent spatial long-term memory and learning. Our results highlight the role of NF-kappaB p50 in hippocampal neurogenesis and in short-term spatial memory.


Asunto(s)
Hipocampo/crecimiento & desarrollo , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/psicología , Memoria a Corto Plazo , Subunidad p50 de NF-kappa B/deficiencia , Envejecimiento , Animales , Bromodesoxiuridina , Recuento de Células , Diferenciación Celular , Proliferación Celular , Supervivencia Celular , Hipocampo/patología , Aprendizaje , Masculino , Trastornos de la Memoria/etiología , Ratones , Ratones Noqueados , Neuronas/patología , Células Madre/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA